726 related articles for article (PubMed ID: 31539129)
1. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
[TBL] [Abstract][Full Text] [Related]
2. Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer.
Zhu LF; Song LD; Xu Q; Zhan JF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5122-5132. PubMed ID: 31298365
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p.
Zhang L; Chi B; Chai J; Qin L; Zhang G; Hua P; Jin C
Mol Biotechnol; 2021 Oct; 63(10):933-940. PubMed ID: 34115289
[TBL] [Abstract][Full Text] [Related]
4. ZEB1-AS1 is associated with poor prognosis in non-small-cell lung cancer and influences cell migration and apoptosis by repressing ID1.
Jin J; Wang H; Si J; Ni R; Liu Y; Wang J
Clin Sci (Lond); 2019 Jan; 133(2):381-392. PubMed ID: 30626729
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ADAMTS9-AS1 knockdown restricts cell proliferation and EMT in non-small cell lung cancer.
Li Z; Yue G; Zhang T; Wu J; Tian X
Histol Histopathol; 2021 Oct; 36(10):1063-1072. PubMed ID: 34085704
[TBL] [Abstract][Full Text] [Related]
6. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
8. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
[TBL] [Abstract][Full Text] [Related]
9. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
10. SBF2-AS1: An oncogenic lncRNA in small-cell lung cancer.
Zhang Y; Li Y; Han L; Zhang P; Sun S
J Cell Biochem; 2019 Sep; 120(9):15422-15428. PubMed ID: 31050364
[TBL] [Abstract][Full Text] [Related]
11. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
13. lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway.
Tang XD; Zhang DD; Jia L; Ji W; Zhao YS
Cell Physiol Biochem; 2018; 50(1):179-195. PubMed ID: 30278439
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
Zhang G; An X; Zhao H; Zhang Q; Zhao H
Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833
[TBL] [Abstract][Full Text] [Related]
15. FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.
Ji T; Zhang Y; Wang Z; Hou Z; Gao X; Zhang X
Cancer Biomark; 2020; 29(3):417-427. PubMed ID: 32924985
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
Dong YZ; Meng XM; Li GS
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
[TBL] [Abstract][Full Text] [Related]
18. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway.
Sun QS; Luo M; Zhao HM; Sun H
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4210-4219. PubMed ID: 31173292
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
